Moderna stock drops 12% after 177% surge: Here’s what Wall Street says about MRNA
By TodayTelugu Desk1 min read3 views

Moderna stock falls 12% after a 177% surge as investors weigh the intismeran cancer vaccine win, future demand, pricing and other cancer trials.
Sending Money to India?
Better USD → INR rates, lower fees.
Advertisement
Related News
Comments
Login to leave a comment







